ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995